Back to Rankings

GRDN

Guardian Pharmacy ServicesB
NYSE / Health Care Equipment & Services
Last Price
At close
2026-08-07
View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+1
B+
Bull case
25%
Probability
Target price
$54.00
+23.2% vs current
Most likely
B
Base case
55%
Probability
Target price
$47.00
+7.2% vs current
B-
Bear case
20%
Probability
Target price
$34.00
-22.4% vs current

AI sentiment snapshot

Latest data as of 2026-08-07
Recent news sentiment (30D)
+28.0
Positive
Company
-
Unavailable
Macro
-
Unavailable
Pulse
+28.0
Positive
Sentiment proxy
+71.2
Score

AI commentary

Primary earnings evidence is positive, with raised guidance and strong adjusted EBITDA growth. The stock was reported by the finance feed at $44.11 on August 7, up 11.8% from the prior close, indicating a favorable immediate market reaction. Analyst revisions and social coverage are unavailable, so conviction remains moderate rather than high.

RankAlpha Sentiment Codex - 2026-08-07
Open post-earnings memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-08-07eventQ2 beat and raised FY2026 guidanceHigh impact

Q2 revenue was $351.8M, adjusted EBITDA $29.7M, and diluted EPS $0.34; management raised FY2026 revenue guidance to $1.43B-$1.45B and adjusted EBITDA guidance to $129M-$131M. [#SEC-8K-2026-08-06]

2026-11-05catalystIRA pricing and reimbursement pressureHigh impact

Management said IRA-related pricing reductions constrained reported revenue growth to 2%, although underlying revenue growth would have been low double digits absent the reductions. Ongoing payor and reimbursement changes remain a downside risk. [#SEC-8K-2026-08-06]

2027-08-07catalystResident growth and footprint expansionHigh impact

Residents served reached approximately 210,000, up 8% year over year. The company also completed the Wellness Concepts acquisition and launched a Lexington, Kentucky greenfield pharmacy. [#SEC-8K-2026-08-06]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-08-07 • Updated nightlySource: Internal modelMethodology